id,sequence,label,source
abrilumab,FDPQDGET,0,jain2017
adalimumab,ITWNSGHI,0,jain2017
alemtuzumab,IRDKAKGYTT,0,jain2017
alirocumab,ISGSGGTT,0,jain2017
anifrolumab,IYPGDSDI,0,jain2017
belimumab,IIPMFGTA,1,jain2017
bimagrumab,INPVSGST,1,jain2017
blosozumab,SDPEIGDT,1,jain2017
bococizumab,ISPFGGRT,1,jain2017
briakinumab,IRYDGSNK,1,jain2017
canakinumab,IWYDGDNQ,0,jain2017
carlumab,IIPIFGTA,1,jain2017
certolizumab,INTYIGEP,0,jain2017
cixutumumab,IIPIFGTA,1,jain2017
clazakizumab,IYGSDET,0,jain2017
codrituzumab,LDPKTGDT,1,jain2017
dacetuzumab,VIPNAGGT,0,jain2017
dalotuzumab,ISYDGTN,1,jain2017
daratumumab,ISGSGGGT,0,jain2017
denosumab,ITGSGGST,1,jain2017
duligotuzumab,ISAAGGYT,1,jain2017
dupilumab,ISGSGGNT,1,jain2017
eculizumab,ILPGSGST,0,jain2017
efalizumab,IHPSDSET,0,jain2017
elotuzumab,INPDSSTI,0,jain2017
emibetuzumab,VNPNRRGT,1,jain2017
etrolizumab,ISYSGST,1,jain2017
farletuzumab,ISSGGSYT,0,jain2017
fasinumab,FDPEDGET,0,jain2017
ficlatuzumab,INPTNGHT,0,jain2017
figitumumab,ISGSGGTT,1,jain2017
foralumab,IWYDGSKK,1,jain2017
fresolimumab,VIPIVDIA,0,jain2017
gantenerumab,INASGTRT,1,jain2017
gevokizumab,IWWDGDE,0,jain2017
guselkumab,IDPSNSYT,1,jain2017
ibalizumab,INPYNDGT,0,jain2017
imgatuzumab,FNPNSGYS,1,jain2017
inotuzumab,INPGNNYA,1,jain2017
ixekizumab,INPMYGTT,1,jain2017
lenzilumab,INAGNGNT,1,jain2017
lintuzumab,IYPYNGGT,0,jain2017
lumiliximab,ISSSGDPT,0,jain2017
matuzumab,FNPSNGRT,0,jain2017
mavrilimumab,FDPEENEI,0,jain2017
mepolizumab,IWASGGT,0,jain2017
mogamulizumab,ISSASTYS,0,jain2017
natalizumab,IDPANGYT,0,jain2017
necitumumab,IYYSGST,0,jain2017
nivolumab,IWYDGSKR,0,jain2017
obinutuzumab,IFPGDGDT,0,jain2017
ofatumumab,ISWNSGSI,0,jain2017
olokizumab,MRNKNYQYGT,0,jain2017
omalizumab,ITYDGST,0,jain2017
onartuzumab,IDPSNSDT,0,jain2017
otlertuzumab,IDPYYGGT,0,jain2017
ozanezumab,INPSNGGT,1,jain2017
palivizumab,IWWDDKK,0,jain2017
panitumumab,IYYSGNT,0,jain2017
panobacumab,INSDGST,0,jain2017
parsatuzumab,INLDNSGT,1,jain2017
patritumab,INHSGST,1,jain2017
pertuzumab,VNPNSGGS,0,jain2017
pinatuzumab,IYPGDGDT,0,jain2017
polatuzumab,ILPGGGDT,0,jain2017
ponezumab,IDPATGNT,1,jain2017
radretumab,ISGSSGTT,0,jain2017
ramucirumab,ISSSSSYI,0,jain2017
ranibizumab,INTYTGEP,1,jain2017
reslizumab,IWSNGDT,0,jain2017
robatumumab,IDTRGAT,1,jain2017
romosozumab,INPNSGGA,0,jain2017
sarilumab,ISWNSGRI,0,jain2017
siltuximab,ISSGGSYT,0,jain2017
simtuzumab,INPGSGGT,1,jain2017
sirukumab,ISPGGSWT,1,jain2017
tigatuzumab,ISSGGSYT,0,jain2017
tildrakizumab,IFPASGSA,0,jain2017
tocilizumab,ISYSGIT,0,jain2017
tovetumab,ISSSGSII,0,jain2017
trastuzumab,IYPTNGYT,0,jain2017
ustekinumab,MSPVDSDI,1,jain2017
vedolizumab,IDPSESNT,0,jain2017
veltuzumab,IYPGMGDT,0,jain2017
visilizumab,INPRSGYT,1,jain2017
zanolimumab,INHSGST,0,jain2017
